Skip to main content
. Author manuscript; available in PMC: 2020 Sep 10.
Published in final edited form as: Annu Rev Pharmacol Toxicol. 2018 Oct 8;59:577–603. doi: 10.1146/annurev-pharmtox-010818-021154

Figure 2.

Figure 2

The global allele frequency difference for rs2242480, a single nucleotide polymorphism associated with increased warfarin clearance and lower platelet activation in clopidogrel-treated coronary artery disease patients. As shown, the frequency of the T allele (risk allele) varies widely between populations. Although the frequency is very high in African ancestry populations, followed by South American and Asian populations, it is comparatively very low in European populations.